Infinity Holdings, along with persons acting in concert with Jagsonpal Pharmaceuticals Limited, has submitted a disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure confirms that no encumbrance of shares, either directly or indirectly, was made by the promoters during the financial year ended March 31, 2026. This declaration is in accordance with the SEBI regulations, ensuring transparency regarding shareholding and potential changes in ownership structures. The filing was made to the BSE Ltd and the National Stock Exchange of India Ltd on April 06, 2026.
